BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19022564)

  • 1. Apical membrane localization of glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer.
    Hirakawa H; Nakayama T; Shibata K; Mihara Y; Taba M; Nagayasu T; Sekine I
    Cancer Lett; 2009 Mar; 275(1):158-62. PubMed ID: 19022564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear expression of glycogen synthase kinase-3β and lack of membranous β-catenin is correlated with poor survival in colon cancer.
    Salim T; Sjölander A; Sand-Dejmek J
    Int J Cancer; 2013 Aug; 133(4):807-15. PubMed ID: 23389968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
    Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
    Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.
    Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R
    Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cellular localization of glycogen synthase kinase 3beta in the digestive tract with cancer development.
    Hirakawa H; Nakayama T; Shibata K; Sekine I
    Oncol Rep; 2009 Sep; 22(3):481-5. PubMed ID: 19639192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop.
    Jamieson C; Sharma M; Henderson BR
    Traffic; 2011 Aug; 12(8):983-99. PubMed ID: 21496192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta.
    Li J; Mizukami Y; Zhang X; Jo WS; Chung DC
    Gastroenterology; 2005 Jun; 128(7):1907-18. PubMed ID: 15940626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen Synthase Kinase 3β Is Positively Regulated by Protein Kinase Cζ-Mediated Phosphorylation Induced by Wnt Agonists.
    Tejeda-Muñoz N; González-Aguilar H; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    Mol Cell Biol; 2015 Dec; 36(5):731-41. PubMed ID: 26711256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.
    Jeong WJ; Yoon J; Park JC; Lee SH; Lee SH; Kaduwal S; Kim H; Yoon JB; Choi KY
    Sci Signal; 2012 Apr; 5(219):ra30. PubMed ID: 22494971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic function of DACT1 in colon cancer through the regulation of β-catenin.
    Yuan G; Wang C; Ma C; Chen N; Tian Q; Zhang T; Fu W
    PLoS One; 2012; 7(3):e34004. PubMed ID: 22470507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia.
    Umar S; Wang Y; Morris AP; Sellin JH
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G599-607. PubMed ID: 17053159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
    Khor TO; Gul YA; Ithnin H; Seow HF
    Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
    Soda M; Willert K; Kaushansky K; Geddis AE
    Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.
    Haraguchi K; Ohsugi M; Abe Y; Semba K; Akiyama T; Yamamoto T
    Oncogene; 2008 Jan; 27(3):274-84. PubMed ID: 17621269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
    Yue H; Lu F; Shen C; Quan JM
    Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.